Midazolam Hydrochloride 1mg/mL Injectable Solution from Japan
This sterile injectable solution contains midazolam hydrochloride at 1mg/mL concentration, put up in pre-filled 2mL syringes for single-dose administration. It is used primarily as a sedative for procedural sedation and preoperative anxiolysis in therapeutic settings. Classified under HTS 3004.90.92.38 due to its midazolam content in measured doses for central nervous system effects as an anticonvulsant, hypnotic, or sedative.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Obtain FDA approval and NDC registration prior to import; include batch certificates and stability data
• Verify controlled substance scheduling (Schedule IV) for DEA compliance
• Avoid repackaging to maintain measured dose integrity